USE OF ANTI-ANDROGENIC 5Α-REDUCTASE INHIBITORS AND RISK OF OESOPHAGEAL AND GASTRIC CANCER BY HISTOLOGICAL TYPE AND ANATOMICAL SUB-SITE
Giola Santoni 1
Sirus Rabbani 1
Shao-Hua Xie 1
Jesper Lagergren 1
1 Karolinska Institutet, Stockholm, Sweden
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]